The inspection wrapped up on December 9, with no critical observations, three major observations and a few minor ones.
Alkem Laboratories told the exchanges on Wednesday, December 10, that the Malta Medicines Authority carried out a GMP inspection at its Daman manufacturing facility between December 5 and December 9.
The inspection wrapped up on December 9, 2025, with no critical observations, three major observations and a few minor ones.
The company said it will address these observations within the stipulated timeline for closure.
Shares of Alkem Laboratories Ltd. are currently trading 0.071% lower on Wednesday at ₹5,663.50. The stock is up just 2% so far in 2025.
Continue Reading